Treatment regimens for pregnant women with falciparum malaria (Q38870452)

7 September 2017

1 reference

title

Treatment regimens for pregnant women with falciparum malaria (English)

1 reference

pregnancy-associated malaria

7 September 2017

main subject

Plasmodium falciparum

0 references

malaria

1 reference

based on heuristic

inferred from title

1 reference

1 reference

Brioni R Moore

0 references

Sam Salman

0 references

Timothy M E Davis

1 reference

7 September 2017

publication date

20 June 2016

1 reference

Expert Review of Anti-infective Therapy

7 September 2017

published in

1 reference

7 September 2017

1 reference

7 September 2017

1 reference

7 September 2017

page(s)

691-704

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

7 September 2017

1 reference

Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Epidemiology and burden of malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Malaria in pregnancy in the Asia-Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

The impact of placental malaria on gestational age and birth weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

New medicines for tropical diseases in pregnancy: catch-22.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Antimalarial drugs in pregnancy: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Antimalarial drugs and pregnancy: safety, pharmacokinetics, and pharmacovigilance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Severe embryotoxicity of artemisinin derivatives in experimental animals, but possibly safe in pregnant women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Exposure to artemether-lumefantrine (Coartem) in first trimester pregnancy in an observational study in Zambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Patterns of anti-malarial drug treatment among pregnant women in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Malaria: an update on current chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Drugs in pregnancy. Pharmacokinetics in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Using pharmacokinetics to predict the effects of pregnancy and maternal-infant transfer of drugs during lactation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pharmacokinetics of Sulfadoxine-Pyrimethamine in HIV-Infected and Uninfected Pregnant Women in Western Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pharmacokinetics of sulfadoxine and pyrimethamine in intermittent preventive treatment of malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pharmacokinetics of amodiaquine and desethylamodiaquine in pregnant and postpartum women with Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Use of quantitative pharmacology tools to improve malaria treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Use of artemether-lumefantrine to treat malaria during pregnancy: what do we know and need to know?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Treating severe malaria in pregnancy: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Prevention and treatment of malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Antimalarial drugs and glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Glucose turnover in pregnant women with acute malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Quinine pharmacokinetics and toxicity in pregnant and lactating women with falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Treatment of severe falciparum malaria during pregnancy with quinidine and exchange transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pharmacokinetic properties of artemether, dihydroartemisinin, lumefantrine, and quinine in pregnant women with uncomplicated plasmodium falciparum malaria in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Population pharmacokinetics and clinical response for artemether-lumefantrine in pregnant and nonpregnant women with uncomplicated Plasmodium falciparum malaria in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Preliminary study of quinine pharmacokinetics in pregnant women with malaria-HIV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Update on genetic markers of quinine resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Randomized comparison of quinine-clindamycin versus artesunate in the treatment of falciparum malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Quinine for the treatment of malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Understanding the pharmacokinetics of Coartem

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Improving the role and contribution of pharmacokinetic analyses in antimalarial drug clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Investigation of reproductive toxicity of piperaquine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Cardiotoxicity of antimalarial drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Mefloquine pharmacokinetics in pregnant women with acute falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Randomized comparison of mefloquine-artesunate versus quinine in the treatment of multidrug-resistant falciparum malaria in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Post-malaria neurological syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

The effects of mefloquine treatment in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Randomized trial of artesunate+amodiaquine, sulfadoxine-pyrimethamine+amodiaquine, chlorproguanal-dapsone and SP for malaria in pregnancy in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

The safety of amodiaquine use in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Artesunate combinations for treatment of malaria: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Artesunate plus sulfadoxine-pyrimethamine in the treatment of uncomplicated Plasmodium falciparum malaria during pregnancy in eastern Sudan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

A randomized controlled pilot trial of azithromycin or artesunate added to sulfadoxine-pyrimethamine as treatment for malaria in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies and Pfdhfr and Pfdhps mutant alleles

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2016.1202758

10.1080/14787210.2016.1202758

21 January 2018

Identifiers

DOI

1 reference

release_3ibp43v2afad5iutldacq32j24

7 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/3ibp43v2afad5iutldacq32j24

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference